Polymer-based nanocarriers to transport therapeutic biomacromolecules across the blood-brain barrier
Acta Biomaterialia · 2025-04 · 196 · 17-49
DOI: 10.1016/j.actbio.2025.02.065 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2025-04. Verfasst von Elena Romero-Ben und 10 weiteren Autor:innen. Beteiligte Einrichtung: POLYMAT, Applied Chemistry Department, Faculty of Chemistry, University of the Basque Country UPV/EHU, Paseo Manuel de Lardizabal 3, Donostia-San Seb…. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Polymers, Nanoparticles, Drug Carriers. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 320 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Commission Marie Sklodowska-Curie Actions, Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación.
Abstract (Originalsprache)
Therapeutic biomacromolecules such as genetic material, antibodies, growth factors and enzymes represent a novel therapeutic alternative for neurological diseases and disorders. In comparison to traditional therapeutics, which are mainly based on small molecular weight drugs that address the symptoms of these disorders, therapeutic biomacromolecules can reduce undesired side effects and target specific pathological pathways, thus paving the way towards personalized medicine. However, these biomacromolecules undergo degradation/denaturation processes in the physiological environment and show poor capacity to cross the blood-brain barrier (BBB). Consequently, they rarely reach the central nervous system (CNS) in their active form. Herein, we critically overview several polymeric nanocarriers that can protect and deliver therapeutic biomacromolecules across the BBB. Polymeric nanocarriers are first categorized based on their architecture (biodegradable solid nanoparticles, nanogels, dendrimers, self-assembled nanoparticles) that ultimately determines their physico-chemical properties and function. The available polymeric formulations are then thoroughly analyzed, placing particular attention on those strategies that ensure the stability of the biomacromolecules during their encapsulation process and promote their passage across the BBB by controlling their physical (e.g., mechanical properties, size, surface charge) and chemical (e.g., surface functional groups, targeting motifs) properties. Accordingly, this review gives a unique perspective on polymeric nanocarriers for the delivery of therapeutic biomacromolecules across the BBB, representing a concise, complete and easy-to-follow guide, which will be of high interest for chemists, material scientists, pharmacologists, and biologists. Besides, it also provides a critical perspective about the limited clinical translation of these systems. STATEMENT OF SIGNIFICANCE: The increasing incidence of central nervous system disorders is a major health concern. The use of therapeutic biomacromolecules has been placed in the spotlight of many investigations. However, reaching therapeutic concentration levels of biomacromolecules in the central nervous system is restricted by the blood-brain barrier and, thus, this represents the main clinical challenge when developing efficient therapies. Herein, we provide a critical discussion about the use of polymeric nanocarriers to deliver therapeutic biomacromolecules into the central nervous system, highlighting potential future directions to overcome the current challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- POLYMAT, Applied Chemistry Department, Faculty of Chemistry, University of the Basque Country UPV/EHU, Paseo Manuel de Lardizabal 3, Donostia-San Sebastián 20018, Spain.
- POLYMAT, Applied Chemistry Department, Faculty of Chemistry, University of the Basque Country UPV/EHU, Paseo Manuel de Lardizabal 3, Donostia-San Sebastián 20018, Spain; Department of Mining-Metallurgy Engineering and M…
- Department of Mining-Metallurgy Engineering and Materials Science, POLYMAT, Bilbao School of Engineering, University of the Basque Country (UPV/EHU), Plaza Torres Quevedo 1, Bilbao 48013, Spain; Istituto Italiano di Tec…
- POLYMAT, Applied Chemistry Department, Faculty of Chemistry, University of the Basque Country UPV/EHU, Paseo Manuel de Lardizabal 3, Donostia-San Sebastián 20018, Spain; Laboratory of Pharmaceutical Nanomaterials Scienc…
- Department of Mining-Metallurgy Engineering and Materials Science, POLYMAT, Bilbao School of Engineering, University of the Basque Country (UPV/EHU), Plaza Torres Quevedo 1, Bilbao 48013, Spain.
- Laboratory of Pharmaceutical Nanomaterials Science, Department of Materials Science and Engineering, Technion - Israel Institute of Technology, Haifa 3200003, Israel.
Förderung
- European Commission Marie Sklodowska-Curie Actions
- Ministerio de Ciencia e Innovación
- Agencia Estatal de Investigación
- Faculty of Science and Engineering, University of Manchester
- Ministerio de Ciencia, Innovación y Universidades
- Federación Española de Enfermedades Raras
- University of the Basque Country
- Basque Foundation for Science
Zitieren
APA
Romero-Ben, E., Goswami, U., Soto-Cruz, J., Mansoori-Kermani, A., Mishra, D., Martin-Saldaña, S., Muñoz-Ugartemendia, J., Sosnik, A., Calderón, M., Beloqui, A., & Larrañaga, A. (2025). Polymer-based nanocarriers to transport therapeutic biomacromolecules across the blood-brain barrier. Acta Biomaterialia, 196, 17-49. https://doi.org/10.1016/j.actbio.2025.02.065
Vancouver
Romero-Ben E, Goswami U, Soto-Cruz J, Mansoori-Kermani A, Mishra D, Martin-Saldaña S, et al. Polymer-based nanocarriers to transport therapeutic biomacromolecules across the blood-brain barrier. Acta Biomaterialia. 2025;196:17-49. doi:10.1016/j.actbio.2025.02.065
BibTeX
@article{RomeroBen2025,
author = {Romero-Ben, Elena and Goswami, Upashi and Soto-Cruz, Jackeline and Mansoori-Kermani, Amirreza and Mishra, Dhiraj and Martin-Saldaña, Sergio and Muñoz-Ugartemendia, Jone and Sosnik, Alejandro and Calderón, Marcelo and Beloqui, Ana and Larrañaga, Aitor},
title = {Polymer-based nanocarriers to transport therapeutic biomacromolecules across the blood-brain barrier},
journal = {Acta Biomaterialia},
year = {2025},
volume = {196},
pages = {17--49},
doi = {10.1016/j.actbio.2025.02.065}
}
EUVIMED